vs
Side-by-side financial comparison of 4D Molecular Therapeutics, Inc. (FDMT) and LXP Industrial Trust (LXP). Click either name above to swap in a different company.
LXP Industrial Trust is the larger business by last-quarter revenue ($86.7M vs $85.1M, roughly 1.0× 4D Molecular Therapeutics, Inc.). LXP Industrial Trust runs the higher net margin — 33.2% vs 22.8%, a 10.4% gap on every dollar of revenue. On growth, 4D Molecular Therapeutics, Inc. posted the faster year-over-year revenue change (8508900.0% vs -14.0%). Over the past eight quarters, 4D Molecular Therapeutics, Inc.'s revenue compounded faster (5412.6% CAGR vs 0.3%).
4D Molecular Therapeutics is a clinical-stage biotechnology company specializing in the research and development of targeted adeno-associated virus (AAV) gene therapies. Its core product candidates address unmet medical needs in ophthalmology, cardiology, and pulmonary disease segments, serving global patient populations with rare and common hard-to-treat conditions.
LXP Industrial Trust is a publicly traded real estate investment trust (REIT) that owns, operates, and invests in high-quality industrial real estate assets, primarily distribution centers, logistics facilities, and light industrial properties across key markets in the United States. Its tenant base covers e-commerce, third-party logistics, and advanced manufacturing sectors, delivering stable long-term returns for its investors.
FDMT vs LXP — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $85.1M | $86.7M |
| Net Profit | $19.4M | $28.8M |
| Gross Margin | — | 81.5% |
| Operating Margin | 17.3% | 34.6% |
| Net Margin | 22.8% | 33.2% |
| Revenue YoY | 8508900.0% | -14.0% |
| Net Profit YoY | 139.1% | — |
| EPS (diluted) | $0.43 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $85.1M | $86.7M | ||
| Q3 25 | $90.0K | $86.9M | ||
| Q2 25 | $15.0K | $87.7M | ||
| Q1 25 | $14.0K | $88.9M | ||
| Q4 24 | $1.0K | $100.9M | ||
| Q3 24 | $3.0K | $85.6M | ||
| Q2 24 | $5.0K | $85.8M | ||
| Q1 24 | $28.0K | $86.3M |
| Q4 25 | $19.4M | $28.8M | ||
| Q3 25 | $-56.9M | $36.3M | ||
| Q2 25 | $-54.7M | $29.1M | ||
| Q1 25 | $-48.0M | $19.0M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-43.8M | $6.3M | ||
| Q2 24 | $-35.0M | $5.4M | ||
| Q1 24 | $-32.4M | $-269.0K |
| Q4 25 | — | 81.5% | ||
| Q3 25 | — | 82.3% | ||
| Q2 25 | — | 81.9% | ||
| Q1 25 | — | 80.7% | ||
| Q4 24 | — | 85.3% | ||
| Q3 24 | — | 82.5% | ||
| Q2 24 | — | 82.0% | ||
| Q1 24 | — | 82.4% |
| Q4 25 | 17.3% | 34.6% | ||
| Q3 25 | -67983.3% | 50.4% | ||
| Q2 25 | -396373.3% | 33.7% | ||
| Q1 25 | -383007.1% | 21.8% | ||
| Q4 24 | — | — | ||
| Q3 24 | -1704400.0% | 7.9% | ||
| Q2 24 | -849120.0% | 6.9% | ||
| Q1 24 | -136200.0% | 1.0% |
| Q4 25 | 22.8% | 33.2% | ||
| Q3 25 | -63195.6% | 41.7% | ||
| Q2 25 | -364386.7% | 33.2% | ||
| Q1 25 | -342657.1% | 21.4% | ||
| Q4 24 | — | — | ||
| Q3 24 | -1461433.3% | 7.4% | ||
| Q2 24 | -699060.0% | 6.3% | ||
| Q1 24 | -115717.9% | -0.3% |
| Q4 25 | $0.43 | — | ||
| Q3 25 | $-1.01 | $0.12 | ||
| Q2 25 | $-0.98 | $0.09 | ||
| Q1 25 | $-0.86 | $0.06 | ||
| Q4 24 | — | — | ||
| Q3 24 | $-0.79 | $0.02 | ||
| Q2 24 | $-0.63 | $0.01 | ||
| Q1 24 | $-0.66 | $-0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $402.7M | $170.4M |
| Total DebtLower is stronger | — | $1.4B |
| Stockholders' EquityBook value | $505.7M | $2.0B |
| Total Assets | $566.7M | $3.5B |
| Debt / EquityLower = less leverage | — | 0.66× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $402.7M | $170.4M | ||
| Q3 25 | $305.1M | $229.7M | ||
| Q2 25 | $293.2M | $71.0M | ||
| Q1 25 | $321.4M | $70.9M | ||
| Q4 24 | $424.9M | $101.8M | ||
| Q3 24 | $501.9M | $55.0M | ||
| Q2 24 | $541.9M | $48.7M | ||
| Q1 24 | $525.9M | $293.8M |
| Q4 25 | — | $1.4B | ||
| Q3 25 | — | $1.5B | ||
| Q2 25 | — | $1.5B | ||
| Q1 25 | — | $1.5B | ||
| Q4 24 | — | $1.6B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $505.7M | $2.0B | ||
| Q3 25 | $369.0M | $2.1B | ||
| Q2 25 | $420.9M | $2.1B | ||
| Q1 25 | $469.7M | $2.1B | ||
| Q4 24 | $510.6M | $2.1B | ||
| Q3 24 | $552.9M | $2.1B | ||
| Q2 24 | $588.3M | $2.1B | ||
| Q1 24 | $600.6M | $2.2B |
| Q4 25 | $566.7M | $3.5B | ||
| Q3 25 | $424.0M | $3.7B | ||
| Q2 25 | $473.6M | $3.7B | ||
| Q1 25 | $515.7M | $3.8B | ||
| Q4 24 | $560.4M | $3.8B | ||
| Q3 24 | $604.0M | $3.9B | ||
| Q2 24 | $620.1M | $3.9B | ||
| Q1 24 | $629.9M | $4.2B |
| Q4 25 | — | 0.66× | ||
| Q3 25 | — | 0.72× | ||
| Q2 25 | — | 0.72× | ||
| Q1 25 | — | 0.73× | ||
| Q4 24 | — | 0.75× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $28.6M | $188.7M |
| Free Cash FlowOCF − Capex | $28.5M | — |
| FCF MarginFCF / Revenue | 33.5% | — |
| Capex IntensityCapex / Revenue | 0.1% | — |
| Cash ConversionOCF / Net Profit | 1.47× | 6.56× |
| TTM Free Cash FlowTrailing 4 quarters | $-109.9M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $28.6M | $188.7M | ||
| Q3 25 | $-46.5M | $63.5M | ||
| Q2 25 | $-43.4M | $44.3M | ||
| Q1 25 | $-47.8M | $39.0M | ||
| Q4 24 | $-134.6M | $211.2M | ||
| Q3 24 | $-29.4M | $64.6M | ||
| Q2 24 | $-30.2M | $38.5M | ||
| Q1 24 | $-29.1M | $38.9M |
| Q4 25 | $28.5M | — | ||
| Q3 25 | $-46.6M | — | ||
| Q2 25 | $-43.4M | — | ||
| Q1 25 | $-48.4M | — | ||
| Q4 24 | $-138.4M | — | ||
| Q3 24 | $-31.2M | — | ||
| Q2 24 | $-30.6M | — | ||
| Q1 24 | $-29.8M | — |
| Q4 25 | 33.5% | — | ||
| Q3 25 | -51765.6% | — | ||
| Q2 25 | -289620.0% | — | ||
| Q1 25 | -345635.7% | — | ||
| Q4 24 | -13837100.0% | — | ||
| Q3 24 | -1038966.7% | — | ||
| Q2 24 | -611840.0% | — | ||
| Q1 24 | -106421.4% | — |
| Q4 25 | 0.1% | — | ||
| Q3 25 | 101.1% | — | ||
| Q2 25 | 440.0% | — | ||
| Q1 25 | 4507.1% | — | ||
| Q4 24 | 378600.0% | — | ||
| Q3 24 | 59266.7% | — | ||
| Q2 24 | 6980.0% | — | ||
| Q1 24 | 2535.7% | — |
| Q4 25 | 1.47× | 6.56× | ||
| Q3 25 | — | 1.75× | ||
| Q2 25 | — | 1.52× | ||
| Q1 25 | — | 2.05× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 10.18× | ||
| Q2 24 | — | 7.09× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
